✦ LIBER ✦

T cell activation by cross-linking anti-CD3 antibodies with second anti-T cell antibodies: dual antibody cross-linking mimics physical monocyte interaction

✍ Scribed by Christoph Walker; Florence Bettens; Werner J. Pichler

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 814 KB
Volume: 17
Category: Article
ISSN: 0014-2980
DOI: 10.1002/eji.1830171114

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activation of T cells by cross-linking a

Activation of T cells by cross-linking an anti-CD3 antibody with a second anti-T cell antibody: mechanism and subset-specific activation

✍ Christoph Walker; Florence Bettens; Werner J. Pichler 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 852 KB

Targeting of T lymphocytes against egf-r

Targeting of T lymphocytes against egf-receptor+ tumor cells by bispecific monoclonal antibodies: Requirement of CD3 molecule cross-linking for t-cell activation

✍ Silvano Ferrini; Anna Cambiaggi; Sabrina Sforzini; Sabrina Marciano; Silvana Can 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 835 KB

NKG2A is a marker for acquisition of reg

NKG2A is a marker for acquisition of regulatory function by human CD8+ T cells activated with anti-CD3 antibody

✍ Vitaly Ablamunits; Octavian Henegariu; Paula Preston-Hurlburt; Kevan C. Herold 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB 👁 1 views

## Abstract Treatment with anti‐CD3 mAb modulates immune responses that cause type 1 diabetes and other diseases. CD8^+^ Tregs can be induced in vitro and in vivo by mAb. However, 1/3 of patients do not respond to drug therapy and in an equal proportion, anti‐CD3 mAb does not induce Tregs in vitro.

Treatment of the P815 murine mastocytoma

Treatment of the P815 murine mastocytoma with cisplatin or etoposide up-regulates cell-surface Fas (CD95) expression and increases sensitivity to anti-Fas antibody-mediated cytotoxicity and to lysis by anti-CD3-activated killer-T cells

✍ Brent A. Williams; Andrew P. Makrigiannis; Jonathan Blay; David W. Hoskin 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 122 KB 👁 2 views

We have investigated the effect of pre-treatment with the anti-cancer drugs cisplatin and etoposide on the susceptibility of P815 murine mastocytoma cells to lysis by murine spleen-derived anti-CD3-activated killer-T (AK-T) cells. A 20 hr pre-treatment with cisplatin (0.2-2 microg/ml) or etoposide (